Metabolic health in normal-weight and obese individuals.


Journal

Diabetologia
ISSN: 1432-0428
Titre abrégé: Diabetologia
Pays: Germany
ID NLM: 0006777

Informations de publication

Date de publication:
04 2019
Historique:
received: 05 07 2018
accepted: 22 10 2018
pubmed: 21 12 2018
medline: 19 2 2020
entrez: 21 12 2018
Statut: ppublish

Résumé

Cardiovascular complications are commonly associated with obesity. However, a subgroup of obese individuals may not be at an increased risk for cardiovascular complications; these individuals are said to have metabolically healthy obesity (MHO). In contrast, metabolically unhealthy individuals are at high risk of cardiovascular disease (CVD), irrespective of BMI; thus, this group can include individuals within the normal weight category (BMI 18.5-24.9 kg/m

Identifiants

pubmed: 30569272
doi: 10.1007/s00125-018-4787-8
pii: 10.1007/s00125-018-4787-8
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

558-566

Références

JAMA. 2009 Nov 11;302(18):1993-2000
pubmed: 19903920
Circulation. 2018 Mar 27;137(13):1391-1406
pubmed: 29581366
Circulation. 2018 Jul 24;138(4):345-355
pubmed: 29712712
Circulation. 2014 Jun 24;129(25 Suppl 2):S49-73
pubmed: 24222018
World Health Organ Tech Rep Ser. 1995;854:1-452
pubmed: 8594834
J Am Coll Cardiol. 2015 Jan 6;65(1):101-102
pubmed: 25572516
Lancet Diabetes Endocrinol. 2018 Mar;6(3):249-258
pubmed: 28919065
Int J Obes (Lond). 2015 Sep;39(9):1365-70
pubmed: 25920773
Nat Genet. 2017 Jan;49(1):17-26
pubmed: 27841877
BMJ. 2018 Jun 13;361:k2396
pubmed: 29898951
Medicine (Baltimore). 2016 Apr;95(15):e3384
pubmed: 27082607
N Engl J Med. 2010 Mar 4;362(9):800-11
pubmed: 20200384
Lancet. 2010 Jun 26;375(9733):2215-22
pubmed: 20609967
Eur Heart J. 2018 Feb 1;39(5):397-406
pubmed: 29020414
Medicine (Baltimore). 2015 Oct;94(40):e1705
pubmed: 26448024
Circulation. 2002 Dec 17;106(25):3143-421
pubmed: 12485966
Lancet. 2005 Sep 24-30;366(9491):1059-62
pubmed: 16182882
Cell Metab. 2017 Aug 1;26(2):292-300
pubmed: 28768170
Int J Obes (Lond). 2017 Jan;41(1):170-177
pubmed: 27748744
Eur J Endocrinol. 2015 Nov;173(5):703-8
pubmed: 26286585
Curr Diab Rep. 2018 May 19;18(7):40
pubmed: 29779155
Int J Cardiol. 2013 Oct 12;168(5):4761-8
pubmed: 23972953
Lancet Diabetes Endocrinol. 2013 Oct;1(2):152-62
pubmed: 24622321
Metabolism. 2015 Aug;64(8):862-71
pubmed: 25861921
J Clin Endocrinol Metab. 2016 Nov;101(11):4117-4124
pubmed: 27552544
J Epidemiol Community Health. 2016 Oct;70(10):1024-31
pubmed: 27126492
Int J Obes (Lond). 2015 Feb;39(2):228-34
pubmed: 24984752
Eur J Prev Cardiol. 2016 Jun;23(9):956-66
pubmed: 26701871
Diabetes Care. 2013 Aug;36(8):2388-94
pubmed: 23491523
JAMA. 2018 Jul 17;320(3):223-225
pubmed: 29955807
N Engl J Med. 1997 Apr 17;336(16):1117-24
pubmed: 9099655
Diabetes. 1998 May;47(5):699-713
pubmed: 9588440
N Engl J Med. 2018 Jun 21;378(25):e34
pubmed: 29897866
Ann Intern Med. 2013 Dec 3;159(11):758-69
pubmed: 24297192
N Engl J Med. 2008 Nov 13;359(20):2105-20
pubmed: 19005195
Lancet. 2016 Aug 20;388(10046):776-86
pubmed: 27423262
Int J Obes (Lond). 2019 May;43(5):1093-1101
pubmed: 29777229
J Am Coll Cardiol. 2017 Sep 19;70(12):1429-1437
pubmed: 28911506
Lancet Diabetes Endocrinol. 2018 Sep;6(9):714-724
pubmed: 29859908
Am J Clin Nutr. 2003 May;77(5):1146-55
pubmed: 12716665
Lancet. 2011 Mar 26;377(9771):1085-95
pubmed: 21397319
J Clin Endocrinol Metab. 2013 Jun;98(6):2318-25
pubmed: 23559087
N Engl J Med. 2001 Nov 1;345(18):1291-7
pubmed: 11794147
J Am Coll Cardiol. 2018 May 1;71(17):1857-1865
pubmed: 29699611

Auteurs

Matthias B Schulze (MB)

Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Arthur-Scheunert-Allee 114-116, 14558, Nuthetal, Germany. mschulze@dife.de.
German Center for Diabetes Research (DZD), München-Neuherberg, Germany. mschulze@dife.de.
Institute of Nutritional Sciences, University of Potsdam, Nuthetal, Germany. mschulze@dife.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH